Investigation of the correlation between clinicopathological features such as gender, clinical stage, Lauren classification, differentiation, HER2 status, treatment types, and perforation and mRNA expression level of SLC30A family genes showed that all SLC30A family gene expression was significantly correlated with gender in GC patients (Table 2). The gene discussed is ERBB2; the disease is gastric cancer.